Collateral damage in the war on drugs: HIV risk behaviors among injection drug users

International Journal of Drug Policy

Volumn 10, Issue 1, 1999, Pages 25-38

  Bluthenthal, Ricky N ^a,b,c   Lorvick, Jennifer ^a   Kral, Alex H ^a   Erringer, Elizabeth A ^a   Kahn, James G ^a,d  

^a Urban Health Study   (United States)

^b RAND CORPORATION   (United States)

^c CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Drug paraphernalia; HIV; SSI; Substance use; War on Drugs

Indexed keywords

ALCOHOL; COCAINE; DIAMORPHINE; ILLICIT DRUG;

ARTICLE; BUDGET; CRIMINAL LAW; DRUG LEGISLATION; DRUG TRAFFIC; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; HUMAN RIGHTS; INFECTION RISK; INTERVIEW; INTRAVENOUS DRUG ABUSE; LAW ENFORCEMENT; OFFENDER; POLICY; PRIORITY JOURNAL; PUNISHMENT; SOCIAL SECURITY; SYRINGE; UNITED KINGDOM; UNITED STATES;

EID: 0033048705     PISSN: 09553959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-3959(98)00076-0     Document Type: Article

References (77)

1. Andreas P. Profits, poverty and illegality: the logic of drug corruption. NACLA Report on the Americas. 27:1993;22-29.
2. Barber SL. Supplemental security income recipients for whom the alcoholism and drug addiction provisions appy (DAA recipients): December 1995. Washington D.C.: Office of Program Benefits, Social Security Administration, 1996.
3. Battjes R.J., Pickens R.W., Haverkos H.W., Sloboda Z. HIV risk factors among injecting drug users in five cities. AIDS. 8:1994;681-687.
4. Baum D. Smoke and Mirrors: The War on Drugs and the Politics of Failure. Boston: Little, Brown and Company, 1996.
5. Bennett WJ, DiIulio JJ, Walters JP. Body count, moral poverty. and how to win America's war against crime and drugs. New York: Simon and Schuster, 1996.
6. Bertram E, Blackman M, Sharpe K, Andreas P. Drug War Politics: The Price of Denial. Berkeley, CA: University of California Press, 1996.
7. Bluthenthal RN, Kral AH, Erringer EA, Edlin BR. Drug paraphernalia laws and injection-related infectious disease risk among drug injectors. J. Drug Issues (in press).
8. Bluthenthal R.N., Kral A.H., Lorvick J., Watters J.K. Impact of law enforcement on syringe exchange programs: a look at Oakland and San Francisco. Med. Anthropol. 18:1997;61-83.
9. Bluthenthal RN, Watters JK. Multimethod research: from targeted sampling to HIV risk behaviors. In: Lambert EY, Ashery RS, Needle RH, editors. Qualitative Methods in the Prevention of Drug Abuse and HIV Research, 212-230. Rockville, MD: National Institute on Drug Abuse, 1995.
10. Booth R.E., Koester S.K., Reichardt C.S., Brewster J.T. Quantitative and qualitative methods to assess behavioral change among injection drug users. Drugs. Soc. 7:1993;161-183.
11. Bourgois P., Lettiere M., Quesada J. Social misery and the sanctions of substance abuse: confronting HIV risk among homeless heroin addicts in San Francisco. Social Problems. 44:1997;155-173.
12. Carter D.L. Drug-related corruption of police officers: a contemporary typology. J. Crim. Justice. 18:1990;85-98.
13. Caulkins JP, Rydell CP, Schwabe WL, Chiesa J. Mandatory Minimum Drug Sentences: Throwing Away the Key or the Taxpayers Money? Santa Monica, CA: Rand Corporation, 1997.
14. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report. Atlanta, GA: Public Health Service, 1997.
15. Conviser R., Rutledge J.H. Can public policies limit the spread of HIV among IV drug users? J. Drug Issues. 19:1989;113-128.
16. Day D. Health Emergency 1997: The Spread of Drug-Related AIDS among African Americans and Latinos. Princeton, NJ: Dogwood Center, 1997.
17. Des Jarlais D.C., Friedman S.R., Choopanya K., Vanichsen S., Ward T.P. International epidemiology of HIV and AIDS among injecting drug users. AIDS. 6:1992;1053-1068.
18. Dorgan M. Addicts feed habits with U.S. hand outs. San Jose Mercury News. December 19, 1993.
19. Dowling-Guyer S., Johnson M.E., Fisher D.G. et al. Reliability of drug users self-reported HIV risk behaviors and validity of self-reported recent drug use. Assessment. 1:1994;383-392.
20. Feldman HW, Biernacki P. The ethnography of needle sharing among intravenous drug users and implications for public policies and intervention strategies. In: Battjes RJ, Pickens RW, editors. Needle Sharing among Intravenous Drug Abusers: National and International Perspectives, 28-39. Rockville, MD: National Institute on Drug Abuse, 1988.
21. Fitzgerald R. America's shocking disability scam. In: Reader's Digest. August, 1994, p. 105.
22. Friedman S.R., Jose B., Deren S., Des Jarlais D.C., Neaigus A. Risk factors for human immunodeficiency virus seroconversion among out-of-treatment drug injectors in high and low seroprevalence cities. Am. J. Epidemiol. 142:1995;864-874.
23. Frisman L.K., Rosenheck R. The relationship of public support payments to substance abuse among homeless veterans with mental illness. Psychiat. Services. 48:1997;792-795.
24. Office of Inspector General. Social Security Polices Concerning Drug Addicts and Alcoholics. Washington, D.C.: US Department of Health and Human Services, 1991.
25. Gleghorn A.A., Jones T.S., Doherty M.C., Celentano D.D., Vlahov D. Acquisition and use of needles and syringes by injecting drug users in Baltimore, Maryland. J. Acq. Immune Defic. Synd Human Retrovirol. 10:1995;97-103.
26. Gostin L.O., Lazzarini Z. Prevention of HIV/AIDS among injection drug users: the theory and science of public health and criminal justice approaches to disease prevention. Emory Law J. 46:1997;587-696.
27. Gray M. Drug Crazy: How We Got Into This Mess & How We Can Get Out. New York, NY: Random House, 1998.
28. Grund J-PC, Kaplan CD, Adriaans NFP, Blanken P, Huisman J. The limitations of the concept of needle-sharing: The practice of front-loading (letter). AIDS 1990;4:819-821.
29. Grund J-PC, Heckathorn DD, Broadhead RS, Anthony DL. Eastern Connecticut, IDUs purchase syringes from pharmacies but don't carry syringes. (letter). J Acq Immune Defic Synd Human Retrovirol 1995;10:104-105.
30. Grund J-PC, Friedman SR, Stern LS, Jose B, Neaigus A, Curtis R, Des Jarlais DC. Syringe-mediated drug sharing among injecting drug users: patterns, social context, and implications for transmission of blood-borne pathogens. Social Sci Med 1996;42:691-703.
31. Heimer R, Bluthenthal RN, Singer M, Khoshnood K. Structural impediments to operational syringe-exchange programs. AIDS Public Policy J 1996a;11:169-184.
32. Heimer R., Khoshnood K., Jariwala-Freeman B., Duncan B., Harima Y. Hepatitis in used syringes: the limits of sensitivity of techniques to detect HBV DNA, HCV RNA, and antibodies to HB core and HCV antigens. J. Infect. Dis. 173:1996b;997-1000.
33. Heimer R., Myers S.S., Cadman E.C., Kaplan E.H. Detection by polymerase chain reaction of human immunodeficiency virus type 1 proviral DNA sequences in needles of injecting drug users. J. Infect. Dis. 165:1992;781-782.
34. Holmberg S. The estimated prevalence and incidence of HIV in 96 large US metropolitan areas. Am. J. Pub. Health. 86:1996;642-654.
35. Jose B, Friedman SR, Neaigus A, Curtis R, Grund J-PC, Goldstein MF, Ward T, Des Jarlais DC. Syringe-mediated drug sharing (backloading): a new risk factor for HIV among injecting drug users. AIDS 1993;7:1653-1660.
36. Kleiman MAR. Against Excess: Drug Policy for Results. New York, N.Y.: Basic Books, 1992.
37. Koester S.K. Copping, running, and paraphernalia laws: contextual variables and needle risk behaviors among injection drug users in Denver. Human Org. 53:1994;287-295.
38. Kral A.H., Bluthenthal R.N., Booth R.E., Watters J.K. HIV seroprevalence among street-recruited injecting drug and crack cocaine users in 16 U.S. municipalities. Am. J. Publ. Health. 88:1998;108-113.
39. Kral AH, Lorvick J, Bluthenthal RN. Impact of withdrawal of SSI disability benefits for injection drug users in the San Francisco Bay Area. In: Seventh International Conference on the Reduction of Drug Related Harm. Paris, France, 1997.
40. Latkin C.A., Vlahov D., Anthony J.C. Socially desirable responding and self-reported HIV infection risk behaviors among intravenous drug users. Addiction. 88:1993;517-526.
41. Lurie P., Drucker E. An opportunity lost: HIV infections associated with lack of a national needle-exchange programme in the USA. Lancet. 349:1997;604-608.
42. Miguez M.J., Page J.B., Baum M.K. Illegal drug use and HIV-1 infection in Columbia (letter). The Lancet. 350:1997;1635.
43. Miller RL. Drug Warriors and Their Prey: From Police Power to Police State. New York, NY: Praeger, 1996.
44. Myers S.S., Heimer R., Liu D., Henrard D. HIV DNA and antibodies in syringes from injecting drug users: a comparison of detection techniques. AIDS. 7:1993;925-931.
45. Nadelman E.A. U.S. policy: a bad export. Foreign Policy. 70:1988;83-108.
46. Nadelmann E.A. Commonsense drug policy. Foreign Affairs. 77:1998;111-126.
47. Naik T.N., Sarkar S., Singh H.L., Bhunia S.C., Singh Y.I., Singh P.K., Pal S.C. Intravenous drug users - a new high-risk group for HIV infection in India. AIDS. 5:1991;117-118.
48. Needle RH, Mills AR. Drug Procurement Practices of the Out-of-Treatment Chronic Drug Abuser. Rockville, MD: National Institute on Drug Abuse, 1994.
49. Needle R.N., Fisher D.G., Weatherby N.L. et al. Reliability of self-reported HIV risk behaviors of drug users. Psychol. Addict. Behav. 9:1995;242-250.
50. Reuter P. Hawks ascendant: the punitive trend of American drug policy. Daedalus. 121:1992;15-52.
51. Reuter P., MacCoun R.J. Harm reduction and social policy: should addicts be paid? Drug Alcohol Rev. 15:1996;225-230.
52. Rust M. Social security scam: Uncle Sam as enabler. In: Insight, April 11, 1994, p. 7.
53. Samuels J.F., Vlahov D., Anthony J.C., Solomon L., Celentano D.D. The practice of 'frontloading' among intravenous drug users: association with HIV-antibody (letter). AIDS. 5:1991;343.
54. Satel SL. Hooked: Addicts on welfare. New Republic. May 30, 1994.
55. Satel S.L. When disability benefits make patients sicker. New England J. Med. 333:1995;794-796.
56. Schutz C.G., Vlahov D., Anthony J.C., Graham N.M.H. Comparison of self-reported injection frequencies for past 30 days and 6 months among intravenous drug users. J. Clin. Epidemiol. 47:1994;191-195.
57. Seligman D. The SSI follies. Fortune, June 13, 1994, pp. 151.
58. Shah SM, Shapshak P, Rivers JE, Stewart RV, Weatherby NL, Xin K, Page JB, Chitwood DD, Mash DC, Vlahov D, McCoy CB. Detection of HIV-1 DNA in needle/syringes, paraphernalia, and washes from shooting galleries in Miami: a preliminary laboratory report. J Acq Immune Defic Synd Human Retrovirol 1996;11:301-306.
59. Shaner A., Eckman T.C., Roberts L.J., Wilkins J.N., Tucker D.E., Tsuang J.W., Mintz J. Disability income, cocaine use, and repeated hospitalization among schizophrenic cocaine abusers: A government-sponsored revolving door? New England J. Med. 333:1995;777-783.
60. Shaner A., Roberts L.J., Eckman T.A., Tucker D.E., Tsuang J.W., Wilkins J.N., Mintz J. Monetary reinforcement of abstinence from cocaine among mentally ill patients with cocaine dependence. Psychiat. Serv. 48:1997;807-810.
61. Skolnick A.A. Some experts suggest that the nations 'war on drugs' is helping tuberculosis stage a deadly comeback. J. Med. Am. Assoc. 268:1992;3178-3179.
62. Skolnick A.A. Collateral Casualties' climb in drug war. J. Am. Med. Assoc. 271:1994;1636-1639.
63. Stark K., Muller R., Bienzle U., Guggenrnoos-Holzmann I. Frontloading: a risk factor for HIV and hepatitis C virus infection among injecting drug users in Berlin. AIDS. 10:1996;311-317.
64. Stimson G.V. Reconstruction of subregional diffusion of HIV infection among injecting drug users in southeast Asia: implications for early intervention (letter). AIDS. 8:1994;1630-1632.
65. Stimson GV. AIDS and injecting drug use in the United Kingdom, 1987-1993: the policy response and the prevention of the epidemic. Social Sci Med 1995;41:699-716.
66. Tonry M. Malign Neglect: Race, Crime, and Punishment in America. New York, NY: Oxford University Press, 1995.
67. Tullis FL. Unintended Consequences: Illegal Drugs and Drug Policies in Nine Counties. Boulder, CO: L. Rienner, 1995.
68. Waldorf D., Reinarman C., Murphy S. Needle sharing, shooting galleries, and AIDS risks among intravenous drug users in San Francisco: Criminal justice and public health policy. Crim. Justice Policy Rev. 3:1990;321-343.
69. Walsh E. A partisan agenda for cutting the roles of government, labor. Washington Post. October 8, 1994.
70. Watters J.K., Biernacki P. Targeted sampling: options for the study of hidden populations. Social Problems. 36:1989;416-430.
71. Weaver CL. Welfare reform is likely to leave this monster intact. In: Wall Street Journal, April 6, 1994.
72. Wetzstein C. SSI reforms drive drug users, drunks to faith-based welfare. Insight on the News, 1998, January 26, pp. 42-43.
73. Wisotsky S. A Society of Suspects: The War on Drugs and Civil Liberties. Policy Analysis no. 180. Washington, D.C.: Cato Institute, 1992.
74. Wisotsky S, Szasz T. Beyond the War on Drugs: Overcoming a Failed Public Policy. Buffalo, N.Y.: Prometheus Books, 1990.
75. Wright CM. The supplemental security income program: the welfare state's black hole. In: USA Today Magazine. November, 1995, pp. 14-17.
76. Wright NH, Vanichseni S, Akarasewi P, Wasi C, Choopanya K. Was the 1988 HIV epidemic among Bangkok's injecting drug users a common source outbreak. AIDS 1994;8:529-532.
77. Zule W. Risk and reciprocity: HIV and the injection drug user. J. Psychoact. Drugs. 24:1992;243-249.